avns news

Nexeon Begins Clinical Study with Newly Developed Non-Invasive Vagus Nerve Stimulator

LIEGE, Belgium, Oct. 25, 2017 — Nexeon MedSystems Inc (OTCBB: NXNN) announced its completion of an initial series of clinical studies evaluating the utilization of transcutaneous auricular vagus nerve stimulation (aVNS) for the relief of paroxysmal atrial fibrillation.  The Company was previously awarded a €3.4M research grant in relation to this study from the Walloon…